Form 4: NeuroPace CMO Sells Shares for Tax Obligations

NeuroPace Inc.'s Chief Medical Officer, Martha Morrell, disposed of 1,337 shares of common stock to cover tax withholding obligations related to a restricted stock unit award.

Summary

• Martha Morrell, Chief Medical Officer of NeuroPace Inc. (NPCE), disposed of 1,337 shares of common stock.
• The transaction occurred on September 3, 2025, at a price of $9.36 per share.
• These shares were withheld by NeuroPace Inc. to satisfy tax withholding obligations associated with the vesting of a restricted stock unit award.
• Following this transaction, Martha Morrell beneficially owns 83,480 shares of NeuroPace Inc. common stock.

Sentiment

Score: 5

Explanation: This is a neutral, routine transaction for tax purposes related to executive compensation. It does not indicate a change in company fundamentals or insider sentiment regarding the company's future prospects.

Positives

• The transaction is a routine tax withholding event, indicating the vesting of a restricted stock unit award, which is a form of compensation for the Chief Medical Officer.

Negatives

• No direct negative implications are apparent from this routine tax withholding transaction.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, small-scale transaction for tax purposes, not a discretionary sale.
• Employees: Reflects standard executive compensation practices involving restricted stock units.

Key Dates

Recommendation

This Form 4 reports a routine disposition of shares by an insider to cover tax obligations related to the vesting of restricted stock units. Such transactions are common and do not typically signal a change in the company's fundamental outlook or the insider's confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

NeuroPace Inc, NPCE, Martha Morrell, Chief Medical Officer, Form 4, Insider Transaction, Stock Vesting, Tax Withholding, Restricted Stock Unit